These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 8475062)
1. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Blount PL; Meltzer SJ; Yin J; Huang Y; Krasna MJ; Reid BJ Proc Natl Acad Sci U S A; 1993 Apr; 90(8):3221-5. PubMed ID: 8475062 [TBL] [Abstract][Full Text] [Related]
2. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Blount PL; Galipeau PC; Sanchez CA; Neshat K; Levine DS; Yin J; Suzuki H; Abraham JM; Meltzer SJ; Reid BJ Cancer Res; 1994 May; 54(9):2292-5. PubMed ID: 8162566 [TBL] [Abstract][Full Text] [Related]
3. Allelic losses of 17p, 5q, and 18q loci in diploid and aneuploid populations of multiploid colorectal carcinomas. Sugai T; Habano W; Nakamura S; Sato H; Uesugi N; Orii S; Itoh C; Katoh R Hum Pathol; 2000 Aug; 31(8):925-30. PubMed ID: 10987252 [TBL] [Abstract][Full Text] [Related]
4. Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Wu TT; Watanabe T; Heitmiller R; Zahurak M; Forastiere AA; Hamilton SR Am J Pathol; 1998 Jul; 153(1):287-94. PubMed ID: 9665490 [TBL] [Abstract][Full Text] [Related]
5. Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression. Reid BJ; Prevo LJ; Galipeau PC; Sanchez CA; Longton G; Levine DS; Blount PL; Rabinovitch PS Am J Gastroenterol; 2001 Oct; 96(10):2839-48. PubMed ID: 11693316 [TBL] [Abstract][Full Text] [Related]
6. 17p allelic deletions and p53 protein overexpression in Barrett's adenocarcinoma. Blount PL; Ramel S; Raskind WH; Haggitt RC; Sanchez CA; Dean PJ; Rabinovitch PS; Reid BJ Cancer Res; 1991 Oct; 51(20):5482-6. PubMed ID: 1680552 [TBL] [Abstract][Full Text] [Related]
7. Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue. Galipeau PC; Prevo LJ; Sanchez CA; Longton GM; Reid BJ J Natl Cancer Inst; 1999 Dec; 91(24):2087-95. PubMed ID: 10601379 [TBL] [Abstract][Full Text] [Related]
8. Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus. Barrett MT; Sanchez CA; Galipeau PC; Neshat K; Emond M; Reid BJ Oncogene; 1996 Nov; 13(9):1867-73. PubMed ID: 8934532 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathologic and molecular analysis of high-grade dysplasia and early adenocarcinoma in short- versus long-segment Barrett esophagus. Nobukawa B; Abraham SC; Gill J; Heitmiller RF; Wu TT Hum Pathol; 2001 Apr; 32(4):447-54. PubMed ID: 11331963 [TBL] [Abstract][Full Text] [Related]
11. 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagus. Galipeau PC; Cowan DS; Sanchez CA; Barrett MT; Emond MJ; Levine DS; Rabinovitch PS; Reid BJ Proc Natl Acad Sci U S A; 1996 Jul; 93(14):7081-4. PubMed ID: 8692948 [TBL] [Abstract][Full Text] [Related]
12. Base transitions at CpG dinucleotides in the p53 gene are common in esophageal adenocarcinoma. Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Russell SE Cancer Res; 1995 Aug; 55(15):3406-11. PubMed ID: 7614480 [TBL] [Abstract][Full Text] [Related]
14. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Barrett MT; Schutte M; Kern SE; Reid BJ Cancer Res; 1996 Oct; 56(19):4351-3. PubMed ID: 8813122 [TBL] [Abstract][Full Text] [Related]
15. Frequent loss of heterozygosity on chromosomes 1q, 5q, and 17p in human gastric carcinomas. Sano T; Tsujino T; Yoshida K; Nakayama H; Haruma K; Ito H; Nakamura Y; Kajiyama G; Tahara E Cancer Res; 1991 Jun; 51(11):2926-31. PubMed ID: 2032230 [TBL] [Abstract][Full Text] [Related]
16. High frequency of allelic deletion on chromosome 17p in advanced colorectal cancer. Khine K; Smith DR; Goh HS Cancer; 1994 Jan; 73(1):28-35. PubMed ID: 8275434 [TBL] [Abstract][Full Text] [Related]
17. Microallelotyping defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Boland CR; Sato J; Appelman HD; Bresalier RS; Feinberg AP Nat Med; 1995 Sep; 1(9):902-9. PubMed ID: 7585215 [TBL] [Abstract][Full Text] [Related]
18. Barrett's esophagus: a model of human neoplastic progression. Neshat K; Sanchez CA; Galipeau PC; Cowan DS; Ramel S; Levine DS; Reid BJ Cold Spring Harb Symp Quant Biol; 1994; 59():577-83. PubMed ID: 7587115 [No Abstract] [Full Text] [Related]
19. Barrett's oesophagus: microsatellite analysis provides evidence to support the proposed metaplasia-dysplasia-carcinoma sequence. Gleeson CM; Sloan JM; McGuigan JA; Ritchie AJ; Weber JL; Russell SE Genes Chromosomes Cancer; 1998 Jan; 21(1):49-60. PubMed ID: 9443041 [TBL] [Abstract][Full Text] [Related]